Good intentions alone are not enough in 340B. Let’s get informed. The good news is that the growing national scrutiny of how the 340B program operates should be seen not as a threat, but as an opportunity for needed reform.
Recent national reporting in The New York Times highlighted a Senate inquiry into the private contractor that manages key aspects of the 340B program — raising questions about financial incentives, vendor profits, and whether program growth has remained aligned with its original patient-centered purpose.
The federal 340B program was designed to lower costs and expand access. However, it’s not working as it should. There is a transparency problem. To truly serve our community and patients, 340B must operate with transparency, accountability, and a clear connection between financial benefits and patient outcomes.
According to The New York Times article, lawmakers are seeking financial information to better understand how resources flow through the system. This could help 340B become more transparent which is the goal.
For millions of Black Americans who become patients, access to affordable medication is not optional. It is lifesaving. Yet, for many Black communities and other populations facing systemic barriers to care, a few things remain challenging: affordability, access, and clear information about how to navigate the healthcare system.
For patient advocates, especially those focused on health equity, these questions are appropriate and overdue. Communities that have historically been excluded from healthcare decision-making deserve clarity about how programs meant to serve them are actually operating.
When benefits are invisible to patients, trust erodes and equity goals are harder to measure and achieve.
The 340B program was established to help nonprofit hospitals (called “safety net”) care for low income and uninsured patients by allowing them to purchase medications at significant discounts.
In theory, those savings should translate into expanded services, reduced patient costs, and stronger community care programs. In practice, however, reporting and oversight requirements have not kept pace with the program’s rapid growth. Today, a large share of nonprofit hospitals participate, and program volume has increased dramatically.
The problem is that many patients often do not see direct savings at the pharmacy counter. Many do not even know when their prescriptions are processed through 340B arrangements. That disconnect matters.
For communities already facing higher rates of chronic disease, lower insurance coverage rates, and greater cost burdens, every healthcare dollar should be working as hard as possible. Reforming and modernizing 340B can help ensure that happens.
Reform should include clearer reporting on how savings are used, stronger transparency standards for program administrators and participating providers, and more consistent expectations that program generated resources support patient facing services. Examples include medication access programs, chronic disease management, preventive care outreach, and reduced out of pocket costs for those with the greatest financial need.
Importantly, reform is not the same as rollback. Underserved communities cannot afford to lose access tools that work. They also cannot afford inefficiency or opacity in programs designed to serve them.
Patient-centered guardrails would strengthen 340B’s credibility and sustainability. They would also help ensure the program continues to support providers who are genuinely delivering high impact care in medically underserved areas.
From a health equity standpoint, the goal is clear: preserve what works, fix what does not, and measure success based on patient benefit, especially for those with the least margin for error when it comes to healthcare costs, access, and outcomes. Oversight and advocacy are not opposing forces. Together, they can help ensure that 340B fulfills its original promise by expanding access, supporting vulnerable patients, and advancing more equitable healthcare outcomes.
By subscribing, you consent to receive emails from BlackDoctor.com. You may unsubscribe at any time. Privacy Policy & Terms of Service.
